Wei Dong Email

CEO . EdiGene

Beijing,

Location

d***@edigene.com

Primary Email

LinkedIn

Current Roles

Employees:
57
Revenue:
$2.2M
About
EdiGene is a clinical-stage biotechnology company focused on leveraging the cutting-edge genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of genetic diseases and cancer. The company has established its proprietary ex vivo genome-editing platforms for hematopoietic stem cells and T cells, in vivo therapeutic platform based on RNA base editing, and high-throughput genome-editing screening to discover novel targeted therapies.  Founded in 2015, EdiGene is headquartered in Beijing, with subsidiaries in Guangzhou, China and Cambridge, Massachusetts, USA.
EdiGene Address
245 First Street
Beijing, null
China
EdiGene Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.